Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
CGRP
Pharma
Lundbeck stays positive on Rexulti PTSD use despite adcomm vote
There’s a high medical need in PTSD as the last FDA approval in the field was 23 years ago, Lundbeck's R&D chief noted on an investor call.
Angus Liu
Aug 15, 2025 10:50am
Lilly's Emgality fails to top Pfizer's Nurtec in migraine trial
Jun 20, 2023 3:24pm
AbbVie's Qulipta gains approval to prevent chronic migraines
Apr 18, 2023 3:20pm
Teva notched a win in its migraine patent feud with Eli Lilly
Oct 5, 2022 10:35am
Daiichi-Seagen, Roche-Jemincare, AbbVie-I-Mab—Fierce Pharma Asia
Aug 19, 2022 9:35am
Setback at Lundbeck: CGRP migraine drug Vyepti hits trial snag
Aug 18, 2022 12:01pm
